Valuation (60%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 49.64 | N/A |
| PEG Ratio (TTM) | 1.27 | N/A |
| P/S Ratio (TTM) | 5.01 | N/A |
| P/B Ratio (TTM) | 1.74 | N/A |
| P/FCF Ratio (TTM) | 24.15 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.92 | N/A |
| Price to 5YR AVG FCF Ratio | 22.63 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.17% | N/A |
| ROE (TTM) | 3.52% | N/A |
| Net Profit Margin (TTM) | 10.18% | N/A |
| ROIC 5YR AVG | 8.34% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 281.73% | 79.41% | 43.41% |
| Revenue | 0.62% | 22.98% | 3.47% |
| Net Income | 220.63% | 81.70% | 45.44% |
| Cash Flow | 165.74% | 73.48% | 16.41% |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.56 | N/A |
| Quick Ratio (TTM) | 2.97 | N/A |
| D/E Ratio (TTM) | 0.40 | N/A |
| Interest Coverage (TTM) | 3.27 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.79 | N/A |
| LTL to 5YR AVG FCF | 5.50 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.50% | N/A |